Publications by authors named "Neeraj Agarwal"

100Publications

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.

N Engl J Med 2020 Sep 20. Epub 2020 Sep 20.

From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigación Biomédica de Málaga, Málaga (D.O.) - all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire Besançon, Besançon (A.T.-V.), and the Department of Medical Oncology, Institut Bergonié, Bordeaux (G.R.) - all in France; Centre Hospitalier de l'Université de Montréal-Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal (F.S.), and BC Cancer Agency, Vancouver (K.N.C.) - both in Canada; Carolina Urologic Research Center, Myrtle Beach, SC (N.S.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S.S.); Tulane University School of Medicine, New Orleans (O.S.); Huntsman Cancer Institute, University of Utah, Salt Lake City (N.A.); John Wayne Cancer Institute, Santa Monica, CA (P.T.); Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey (M.O.); AstraZeneca, Global Medicines Development, Oncology, Gaithersburg, MD (J.K.); Merck, Kenilworth, NJ (J.B.); and Global Medicines Development, Oncology (C.G.), Precision Medicine and Biosamples, R&D Oncology (C.C.), and Translational Medicine (C.A.A.), AstraZeneca, Cambridge, and the Institute of Cancer Research and Royal Marsden, London (J.B.) - both in the United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2022485DOI Listing
September 2020

Role of Urinary Transforming Growth Factor Beta-B1 and Monocyte Chemotactic Protein-1 as Prognostic Biomarkers in Posterior Urethral Valve.

J Indian Assoc Pediatr Surg 2020 Jul-Aug;25(4):219-224. Epub 2020 Jun 24.

Department of Pediatric Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jiaps.JIAPS_104_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478284PMC
June 2020

PARP Inhibitors in Prostate Cancer: A Promise Delivered.

Eur Urol Oncol 2020 Sep 3. Epub 2020 Sep 3.

Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2020.08.006DOI Listing
September 2020

Improvement in overall survival with Apalutamide, Darolutamide and Enzalutamide in patients with non-metastatic castration-resistant prostate cancer.

Cancer Treat Res Commun 2020 Aug 12;25:100205. Epub 2020 Aug 12.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100205DOI Listing
August 2020

Quest for Ideal Composite Biomarkers for Response to Immunotherapies.

Clin Cancer Res 2020 Aug 5. Epub 2020 Aug 5.

Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-2321DOI Listing
August 2020

Immunotherapy-based combination strategies for advanced urothelial cancer: A long quest.

Cancer 2020 Aug 5. Epub 2020 Aug 5.

Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.33068DOI Listing
August 2020

PARP inhibitors in castration-resistant prostate cancer.

Cancer Treat Res Commun 2020 22;24:100199. Epub 2020 Jul 22.

Huntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, Utah, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100199DOI Listing
July 2020

Flexible Fiber-optic Bronchoscopy-directed Interventions in Children with Congenital Heart Diseases.

Indian J Crit Care Med 2020 May;24(5):340-343

Department of Pediatric Cardiac Sciences, Sir Ganga Ram Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5005/jp-journals-10071-23419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358860PMC
May 2020

Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer.

Cancer Treat Res Commun 2020 14;24:100193. Epub 2020 Jul 14.

Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100193DOI Listing
July 2020

The rapidly evolving treatment landscape of advanced prostate, bladder, and renal cell carcinomas.

Cancer Treat Res Commun 2020 4;24:100190. Epub 2020 Jul 4.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334643PMC
July 2020

Doctor Consultation through Mobile Applications in India: An Overview, Challenges and the Way Forward.

Healthc Inform Res 2020 Apr 30;26(2):153-158. Epub 2020 Apr 30.

Department of Community and Family Medicine, All India Institute of Medical Sciences, Patna, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4258/hir.2020.26.2.153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278514PMC
April 2020

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma.

Cancer Manag Res 2020 20;12:3741-3749. Epub 2020 May 20.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S202973DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246323PMC
May 2020

Advanced Prostate Cancer: Treatment Advances and Future Directions.

Trends Cancer 2020 Aug 10;6(8):702-715. Epub 2020 Jun 10.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2020.04.010DOI Listing
August 2020

COVID-19 and androgen-targeted therapy for prostate cancer patients.

Endocr Relat Cancer 2020 09;27(9):R281-R292

Department of Medicine, Cedars-Sinai Cancer, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-20-0165DOI Listing
September 2020

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].

Authors:
J Alfred Witjes Marek Babjuk Joaquim Bellmunt H Maxim Bruins Theo M De Reijke Maria De Santis Silke Gillessen Nicholas James Steven Maclennan Juan Palou Tom Powles Maria J Ribal Shahrokh F Shariat Theo Van Der Kwast Evanguelos Xylinas Neeraj Agarwal Tom Arends Aristotle Bamias Alison Birtle Peter C Black Bernard H Bochner Michel Bolla Joost L Boormans Alberto Bossi Alberto Briganti Iris Brummelhuis Max Burger Daniel Castellano Richard Cathomas Arturo Chiti Ananya Choudhury Eva Compérat Simon Crabb Stephane Culine Berardino De Bari Willem De Blok Pieter J L De Visschere Karel Decaestecker Konstantinos Dimitropoulos Jose L Dominguez-Escrig Stefano Fanti Valerie Fonteyne Mark Frydenberg Jurgen J Futterer Georgios Gakis Bogdan Geavlete Paolo Gontero Bernhard Grubmüller Shaista Hafeez Donna E Hansel Arndt Hartmann Dickon Hayne Ann M Henry Virginia Hernandez Harry Herr Ken Herrmann Peter Hoskin Jorge Huguet Barbara A Jereczek-Fossa Rob Jones Ashish M Kamat Vincent Khoo Anne E Kiltie Susanne Krege Sylvain Ladoire Pedro C Lara Annemarie Leliveld Estefania Linares-Espinós Vibeke Løgager Anja Lorch Yohann Loriot Richard Meijer M Carmen Mir Marco Moschini Hugh Mostafid Arndt-Christian Müller Christoph R Müller James N'Dow Andrea Necchi Yann Neuzillet Jorg R Oddens Jan Oldenburg Susanne Osanto Wim J G Oyen Luís Pacheco-Figueiredo Helle Pappot Manish I Patel Bradley R Pieters Karin Plass Mesut Remzi Margitta Retz Jonathan Richenberg Michael Rink Florian Roghmann Jonathan E Rosenberg Morgan Rouprêt Olivier Rouvière Carl Salembier Antti Salminen Paul Sargos Shomik Sengupta Amir Sherif Robert J Smeenk Anita Smits Arnulf Stenzl George N Thalmann Bertrand Tombal Baris Turkbey Susanne Vahr Lauridsen Riccardo Valdagni Antoine G Van Der Heijden Hein Van Poppel Mihai D Vartolomei Erik Veskimäe Antoni Vilaseca Franklin A Vives Rivera Thomas Wiegel Peter Wiklund Peter-Paul M Willemse Andrew Williams Richard Zigeuner Alan Horwich

Eur Urol 2020 Jul 21;78(1):e48-e50. Epub 2020 May 21.

Emeritus Professor, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2020.03.017DOI Listing
July 2020

Olaparib for Metastatic Castration-Resistant Prostate Cancer.

N Engl J Med 2020 05 28;382(22):2091-2102. Epub 2020 Apr 28.

From the Institute of Cancer Research and Royal Marsden Hospital, London (J. de Bono), and AstraZeneca, Translational Medicine, Cambridge (C.A.A.) - all in the United Kingdom; Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Malaga (D.O.) - all in Spain; Institut Gustave Roussy, University of Paris Sud, Villejuif (K.F.), and the Department of Medical Oncology, Centre Hospitalier Universitaire Besançon, Besançon (A.T.-V.) - all in France; Centre Hospitalier de l'Université de Montréal-Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal (F.S.), and BC Cancer Agency, Vancouver (K.N.C.) - all in Canada; Carolina Urologic Research Center, Myrtle Beach, SC (N.S.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S.S.); Tulane University School of Medicine, New Orleans (O.S.); Huntsman Cancer Institute, University of Utah Comprehensive Cancer Center, Salt Lake City (N.A.); John Wayne Cancer Institute, Santa Monica, CA (P.T.); Radboud University Medical Center, Nijmegen, the Netherlands (N.M.); AstraZeneca, Global Medicines Development, Oncology, Gaithersburg, MD (C.G., J.K., W.W.); Merck, Kenilworth, NJ (J. Burgents); AstraZeneca, Precision Medicine, Oncology Research and Development, Gaithersburg, MD (A.K.); and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1911440DOI Listing
May 2020

Definitive Chemoradiotherapy for Locally Advanced, Lymph-node Positive, Nonmetastatic Penile Squamous Cell Carcinoma.

Clin Genitourin Cancer 2020 Mar 3. Epub 2020 Mar 3.

Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2020.02.007DOI Listing
March 2020

Performance of revised national tuberculosis control program in Bihar: A situational analysis.

J Family Med Prim Care 2020 Feb 28;9(2):735-739. Epub 2020 Feb 28.

Department of Community and Family Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jfmpc.jfmpc_1028_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113949PMC
February 2020

Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma.

Oncologist 2020 03 15;25(3):186-188. Epub 2019 Oct 15.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066721PMC
March 2020

The addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: safety and efficacy.

Expert Rev Anticancer Ther 2020 Mar 24;20(3):147-150. Epub 2020 Feb 24.

Huntsman Cancer Institute, University of Utah, Salt Lake, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2020.1732212DOI Listing
March 2020

Near-infrared spectroscopy: An important tool during the blalock-taussig shunt.

Ann Card Anaesth 2020 Jan-Mar;23(1):92-94

Department of Pediatric Cardiac Sciences, Sir Ganga Ram Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/aca.ACA_138_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034197PMC
January 2020

Immunization coverage among children aged 12-23 months: A cross sectional study in low performing blocks of Bihar, India.

J Family Med Prim Care 2019 Dec 10;8(12):3949-3955. Epub 2019 Dec 10.

Department of Community and Family Medicine, AIIMS, Patna, Bihar, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jfmpc.jfmpc_619_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924220PMC
December 2019

Germline variants and response to systemic therapy in advanced prostate cancer.

Pharmacogenomics 2020 01;21(1):75-81

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2019-0125DOI Listing
January 2020

Radioisotope Imaging and Therapy for Bone Metastasis in Men With Castration-Resistant Prostate Cancer.

JAMA Oncol 2020 Feb;6(2):225-226

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.4635DOI Listing
February 2020

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Authors:
J Alfred Witjes Marek Babjuk Joaquim Bellmunt H Maxim Bruins Theo M De Reijke Maria De Santis Silke Gillessen Nicholas James Steven Maclennan Juan Palou Tom Powles Maria J Ribal Shahrokh F Shariat Theo Van Der Kwast Evanguelos Xylinas Neeraj Agarwal Tom Arends Aristotle Bamias Alison Birtle Peter C Black Bernard H Bochner Michel Bolla Joost L Boormans Alberto Bossi Alberto Briganti Iris Brummelhuis Max Burger Daniel Castellano Richard Cathomas Arturo Chiti Ananya Choudhury Eva Compérat Simon Crabb Stephane Culine Berardino De Bari Willem De Blok Pieter J L De Visschere Karel Decaestecker Konstantinos Dimitropoulos Jose L Dominguez-Escrig Stefano Fanti Valerie Fonteyne Mark Frydenberg Jurgen J Futterer Georgios Gakis Bogdan Geavlete Paolo Gontero Bernhard Grubmüller Shaista Hafeez Donna E Hansel Arndt Hartmann Dickon Hayne Ann M Henry Virginia Hernandez Harry Herr Ken Herrmann Peter Hoskin Jorge Huguet Barbara A Jereczek-Fossa Rob Jones Ashish M Kamat Vincent Khoo Anne E Kiltie Susanne Krege Sylvain Ladoire Pedro C Lara Annemarie Leliveld Estefania Linares-Espinós Vibeke Løgager Anja Lorch Yohann Loriot Richard Meijer M Carmen Mir Marco Moschini Hugh Mostafid Arndt-Christian Müller Christoph R Müller James N'Dow Andrea Necchi Yann Neuzillet Jorg R Oddens Jan Oldenburg Susanne Osanto Wim J G Oyen Luís Pacheco-Figueiredo Helle Pappot Manish I Patel Bradley R Pieters Karin Plass Mesut Remzi Margitta Retz Jonathan Richenberg Michael Rink Florian Roghmann Jonathan E Rosenberg Morgan Rouprêt Olivier Rouvière Carl Salembier Antti Salminen Paul Sargos Shomik Sengupta Amir Sherif Robert J Smeenk Anita Smits Arnulf Stenzl George N Thalmann Bertrand Tombal Baris Turkbey Susanne Vahr Lauridsen Riccardo Valdagni Antoine G Van Der Heijden Hein Van Poppel Mihai D Vartolomei Erik Veskimäe Antoni Vilaseca Franklin A Vives Rivera Thomas Wiegel Peter Wiklund Andrew Williams Richard Zigeuner Alan Horwich

Eur Urol 2020 02 19;77(2):223-250. Epub 2019 Nov 19.

Emeritus Professor, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.09.035DOI Listing
February 2020

Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors.

Ann Transl Med 2019 Sep;7(Suppl 6):S203

Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2019.07.13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789308PMC
September 2019

Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma.

Oncologist 2019 Oct 15. Epub 2019 Oct 15.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0657DOI Listing
October 2019

First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Eur Urol Oncol 2019 Nov 4;2(6):708-715. Epub 2019 Oct 4.

Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.09.002DOI Listing
November 2019

Can pegylated IL-10 add to a backbone of PD-1 inhibition for solid tumours?

Lancet Oncol 2019 11 25;20(11):1473-1474. Epub 2019 Sep 25.

Division of Medical Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30619-9DOI Listing
November 2019

Investigational MET inhibitors to treat Renal cell carcinoma.

Expert Opin Investig Drugs 2019 Oct 3;28(10):851-860. Epub 2019 Oct 3.

Huntsman Cancer Institute, University of Utah , Salt Lake City , UT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2019.1673366DOI Listing
October 2019

Patterns of treatment in metastatic renal cell carcinoma for older versus younger patients.

J Geriatr Oncol 2020 May 8;11(4):724-726. Epub 2019 Aug 8.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.07.002DOI Listing
May 2020

Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How.

Eur Urol 2020 01 9;77(1):22-23. Epub 2019 Jul 9.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.06.029DOI Listing
January 2020

Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and Challenges.

JAMA Oncol 2019 Jun 27. Epub 2019 Jun 27.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.1008DOI Listing
June 2019

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.

N Engl J Med 2019 07 31;381(1):13-24. Epub 2019 May 31.

From BC Cancer and Vancouver Prostate Centre, Vancouver, Canada (K.N.C.); Huntsman Cancer Institute, University of Utah, Salt Lake City (N.A.); Skåne University Hospital, Lund University, Malmö, Sweden (A.B.); Yonsei University College of Medicine and Gangnam Severance Hospital, Seoul, South Korea (B.H.C.); Liga Norte Riograndense Contra o Câncer, Natal, Brazil (A.J.P.S.G.); Urology of Virginia, Eastern Virginia Medical School, Norfolk (R.G.); Hospital Universitario de Jerez de la Frontera, Cadiz, Spain (A.J.S.); University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany (A.S.M.); Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey (M.O.); Kindai University Hospital Faculty of Medicine, Osaka, Japan (H.U.); Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, San Diego (V.N., J.L., K.Z.), and Janssen Research and Development, Los Angeles (M.K.Y., J.S.L.) - both in California; Janssen Research and Development, Raritan, NJ (S. Cheng, S.M.); and Guy's, King's, and St. Thomas' Hospitals and the Sarah Cannon Research Institute, London (S. Chowdhury).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903307DOI Listing
July 2019

Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement.

Ann Transl Med 2019 03;7(Suppl 1):S18

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://atm.amegroups.com/article/view/23904/23197
Publisher Site
http://dx.doi.org/10.21037/atm.2019.01.50DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462602PMC
March 2019

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.

Oncologist 2019 05 29;24(5):580-583. Epub 2019 Mar 29.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516125PMC
May 2019

The Role of PD-L1 Testing in Advanced Genitourinary Malignancies.

Eur Urol Focus 2020 01 11;6(1):11-13. Epub 2019 Mar 11.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24054569193007
Publisher Site
http://dx.doi.org/10.1016/j.euf.2019.03.003DOI Listing
January 2020

Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors.

Drugs Aging 2019 05;36(5):395-401

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Dr, Suite 2161, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40266-019-00644-1DOI Listing
May 2019

Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer.

Urol Oncol 2019 06 13;37(6):352.e19-352.e24. Epub 2019 Feb 13.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.01.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857455PMC
June 2019

Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.

Cancer Treat Res Commun 2019 6;19:100120. Epub 2019 Feb 6.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Drive Suite 5726, Salt Lake City, UT 84112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2019.100120DOI Listing
September 2019

Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.

Curr Treat Options Oncol 2019 02 11;20(2):14. Epub 2019 Feb 11.

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0611-zDOI Listing
February 2019

Germline Variant in and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC).

Mol Cancer Ther 2019 03 26;18(3):726-729. Epub 2018 Dec 26.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0739DOI Listing
March 2019

Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities.

Res Rep Urol 2018 15;10:205-217. Epub 2018 Nov 15.

Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/unclassified-renal-cell-carcinoma-
Publisher Site
http://dx.doi.org/10.2147/RRU.S154932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248403PMC
November 2018

Biomarkers in renal-cell carcinoma: building on clinical paradigms.

Lancet Oncol 2018 12 8;19(12):1560-1561. Epub 2018 Nov 8.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30674-0DOI Listing
December 2018

The National Eye Institute's Commitment to Career Development of Clinician-Scientists.

JAMA Ophthalmol 2018 12;136(12):1340-1341

Division of Extramural Science Program, National Eye Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaophthalmol.2018.3897DOI Listing
December 2018

Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment.

Am Soc Clin Oncol Educ Book 2018 May;38:363-371

From the Division of Oncology, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT; Division of Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Division of Hematology/Oncology, University of California-San Francisco, Helen Diller Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/EDBK_200967
Publisher Site
http://dx.doi.org/10.1200/EDBK_200967DOI Listing
May 2018

DNA Damage Repair (DDR) Mutations and the Utility of High-Risk Genetics Clinics in Metastatic Castration-Refractory Prostate Cancer (mCRPC).

World J Oncol 2018 Aug 6;9(4):119-122. Epub 2018 Sep 6.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://www.wjon.org/index.php/WJON/article/view/1144
Publisher Site
http://dx.doi.org/10.14740/wjon1144wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134990PMC
August 2018

Editorial Comment.

J Urol 2018 12 4;200(6):1214. Epub 2018 Sep 4.

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.07.096DOI Listing
December 2018

Targeting Endoglin to Treat Metastatic Renal Cell Carcinoma: Lessons from Osler-Weber-Rendu Syndrome.

Oncologist 2019 02 23;24(2):143-145. Epub 2018 Aug 23.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369955PMC
February 2019